Teladoc Health (TDOC)

• Market cap: $1.56B
• 1 day: -0.76%
• 5 days: -6.86%
• 1 month: -9.73%
• 3 months: -4.42%
• 6 months: -9.37%
• Year to date: -4.52%
• 1 year: -53.24%
• 5 years: -90.49%
• 10 years: -68.11%
• Sector: Healthcare
• Industry: Offices & Clinics of Doctors of Medicine

About: Teladoc Health is a virtual health provider with a telehealth platform delivering on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has partnered with employers, health plans, and health systems to offer network access to their members; it has also started to market directly to consumers while expanding its service portfolio.

Employees: 5,600

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

100% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 2 (+1) [Q3]

26% more call options, than puts

Call options by funds: $60.8M | Put options by funds: $48.2M

9.43% less ownership

Funds ownership: 83.31% [Q2] → 73.87% (-9.43%) [Q3]

11% less funds holding

Funds holding: 398 [Q2] → 355 (-43) [Q3]

16% less capital invested

Capital invested by funds: $1.38B [Q2] → $1.16B (-$221M) [Q3]

35% less repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 126

37% less first-time investments, than exits

New positions opened: 59 | Existing positions closed: 94

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $8 12% downside
• Avg. target: $11.80 30% upside
• High target: $14 54% upside

5 analyst ratings

• positive: 3 60%
• neutral: 2 40%
• negative: 0 0%

Piper Sandler Jessica Tassan 25% 1-year accuracy 5 / 20 met price target	43% upside $13	Overweight Reiterated	4 Dec 2024
Goldman Sachs David Roman 46% 1-year accuracy 6 / 13 met price target	54% upside $14	Buy Initiated	15 Nov 2024
Deutsche Bank George Hill 60% 1-year accuracy 6 / 10 met price target	32% upside $12	Hold Maintained	1 Nov 2024
Barclays Steve Valiquette 50% 1-year accuracy 6 / 12 met price target	32% upside $12	Overweight Maintained	31 Oct 2024
TD Cowen Charles Rhyee 30% 1-year accuracy 3 / 10 met price target	12% downside $8	Hold Maintained	31 Oct 2024